Eric Perouse, a pharmacist by training, started his activities in the health sector in the early 80s with the creation of LABORATOIRE PÉROUSE, dedicated to sterilization and then to vascular surgery and vascular access. In 1988, he diversified into silicone technology for plastic surgery with the LABORATOIRE PÉROUSE IMPLANT. Further diversifications were then undertaken in 1990 with thermoplastics for administration systems following the acquisition of SEDAT, now under the name SYMATESE DEVICE.

The acquisition of SADUC from Pasteur Mérieux, involved in the development of collagens at the time in 1997, marked the year in which SYMATESE was founded with Jean-Paul Gérardin, current CEO of SYMATESE.

From 1997 until today, 25 years of research on collagen, hyaluronic acid and other biopolymers and of course the beginning of the research cooperation with L’ORÉAL / EPISKIN in 2001 for an alternative to animal testing of cosmetic products. The dual expertise, unique on the market with collagens and hyaluronic acids, has been an essential key to advancing research on tissue regeneration: the 2 biomaterials play a decisive complementary role in the natural repair processes of living tissues. In 2001, PEROUSE PLASTIE also launched its first silicone gel breast implants.

Discover in detail the mainstages of development through the key partnerships established with leading companies in their markets as well as the launches of own-branded products